Skip to content
Hair Pipeline
← Back to the pipeline

FOL-005

Phase 2InjectableTopicalSignalling peptide

This programme is no longer being actively pursued.

Developed by
Follicum
Current phase
Phase 2

Tests whether it works, at what dose, in a few hundred people.

Indications
Androgenetic alopecia
Also known as
FOL005
Last public activity
March 2021
Record confidence
Low

Development history

  1. Phase 1/2Phase 2

    First Phase 2 trial on record: NCT03467412 — To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

    ClinicalTrials.gov ↗
  2. Phase 1/2

    First Phase 1/2 trial on record: NCT02793557 — Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

    ClinicalTrials.gov ↗

Registered trials

Pulled automatically from ClinicalTrials.gov. Matching is by name and development code, so occasional gaps are possible — tell us if you spot one.

  • NCT04774874Phase 2COMPLETED

    A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

    Follicum AB · n=209 · June 2020

  • NCT03467412Phase 2COMPLETED

    To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

    Follicum AB · n=60 · February 2018

  • NCT02793557Phase 1/2COMPLETED

    Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

    Follicum AB · n=44 · January 2016

Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first.

Sources